Device Spine/Spine Surgery

Creo Mcs, Fenestrated, Sideloading

Payments companies reported to CMS as associated with Creo Mcs, Fenestrated, Sideloading. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$230Kassociated payments (2023-2025)
63clinicians with associated payments
1company reporting

By year

2023 $182K
2024 $48K

Payments reported as associated with Creo Mcs, Fenestrated, Sideloading, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $139K
Orthopaedic Surgery of The Spine $58K
Orthopaedic Surgery $31K
Pediatric Orthopaedic Surgery $1,699
Interventional Cardiology $563
Surgical $475

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Creo Mcs, Fenestrated, Sideloading

These are the largest totals companies reported as associated with Creo Mcs, Fenestrated, Sideloading. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rohit Vasan Tampa, FL Neurological Surgery $32,667.24
Sabino Dagostino Ladson, SC Neurological Surgery $32,667.24
Wilson Ray Saint Louis, MO Neurological Surgery $11,657.34
Praveen Kadimcherla West Orange, NJ Orthopaedic Surgery of The Spine $11,131.70
Osama Kashlan Brooklyn, NY Neurological Surgery $10,955.55
Anthony Russo Great Falls, MT Orthopaedic Surgery of The Spine $10,525.36
Vladimir Sinkov Las Vegas, NV Orthopaedic Surgery $9,857.77
Paul Kraemer Carmel, IN Orthopaedic Surgery of The Spine $9,855.02
Thomas Kingman San Antonio, TX Neurological Surgery $9,855.02
David Rosen Winter Park, FL Neurological Surgery $9,855.02

Prescribed Creo Mcs, Fenestrated, Sideloading?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.